Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
J Mycol Med ; 30(4): 101042, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32919860

ABSTRACT

Candida nivariensis is a cryptic fungal species classified within the Candida glabrata complex. It was described for the first time in 2005 by the means of DNA sequencing. We report a rare case of C. nivariensis deep-seated infection occurring in a 77-year-old man hospitalized for cysto-prostatectomy. Phenotypic testing based on the direct examination and the macroscopic features of the in vitro culture initially suggested C. glabrata species, while MALDI-TOF mass spectrometry enables correct identification. The isolate was found resistant to fluconazole, like in almost 20% of the reported cases. Herein, we present our practical strategy to reliably characterize this rare cryptic species. To date, MALDI-TOF mass spectrometry-based analysis showed very good results for such a purpose.


Subject(s)
Candidemia/microbiology , Saccharomycetales/classification , Saccharomycetales/isolation & purification , Adenocarcinoma of Lung/complications , Adenocarcinoma of Lung/immunology , Adenocarcinoma of Lung/microbiology , Aged , Candidemia/etiology , Carcinoma, Transitional Cell/microbiology , Carcinoma, Transitional Cell/pathology , France , Humans , Lung Neoplasms/complications , Lung Neoplasms/immunology , Lung Neoplasms/microbiology , Male , Microbial Sensitivity Tests , Mycological Typing Techniques/methods , Recurrence , Urinary Bladder Neoplasms/microbiology , Urinary Bladder Neoplasms/pathology , Urothelium/pathology
3.
J Mycol Med ; 30(2): 100970, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32334948

ABSTRACT

A survey of mycology laboratories for antifungal susceptibility testing (AFST) was undertaken in France in 2018, to better understand the difference in practices between the participating centers and to identify the difficulties they may encounter as well as eventual gaps with published standards and guidelines. The survey captured information from 45 mycology laboratories in France on how they perform AFST (number of strains tested, preferred method, technical and quality aspects, interpretation of the MIC values, reading and interpretation difficulties). Results indicated that 86% of respondents used Etest as AFST method, with a combination of one to seven antifungal agents tested. Most of the participating laboratories used similar technical parameters to perform their AFST method and a large majority used, as recommended, internal and external quality assessments. Almost all the participating mycology laboratories (98%) reported difficulties to interpret the MIC values, especially when no clinical breakpoints are available. The survey highlighted that the current AFST practices in France need homogenization, particularly for MIC reading and interpretation.


Subject(s)
Antifungal Agents/therapeutic use , Laboratories , Microbial Sensitivity Tests , Mycology , Professional Practice/statistics & numerical data , Disk Diffusion Antimicrobial Tests/methods , Disk Diffusion Antimicrobial Tests/standards , Disk Diffusion Antimicrobial Tests/statistics & numerical data , Drug Resistance, Fungal , France , History, 21st Century , Humans , Laboratories/standards , Laboratories/statistics & numerical data , Laboratory Proficiency Testing/methods , Laboratory Proficiency Testing/statistics & numerical data , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/standards , Microbial Sensitivity Tests/statistics & numerical data , Mycology/history , Mycology/methods , Mycology/standards , Mycology/statistics & numerical data , Professional Practice/standards , Quality Control , Surveys and Questionnaires
6.
Antimicrob Agents Chemother ; 60(8): 5088-91, 2016 08.
Article in English | MEDLINE | ID: mdl-27297480

ABSTRACT

In vitro susceptibility of 933 Candida isolates, from 16 French hospitals, to micafungin was determined using the Etest in each center. All isolates were then sent to a single center for determination of MICs by the EUCAST reference method. Overall essential agreement between the two tests was 98.5% at ±2 log2 dilutions and 90.2% at ±1 log2 dilutions. Categorical agreement was 98.2%. The Etest is a valuable alternative to EUCAST for the routine determination of micafungin MICs in medical mycology laboratories.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Echinocandins/pharmacology , Lipopeptides/pharmacology , Candida/genetics , Drug Resistance, Fungal/genetics , Micafungin , Microbial Sensitivity Tests
7.
Arch Pediatr ; 23(7): 685-94, 2016 Jul.
Article in French | MEDLINE | ID: mdl-27287709

ABSTRACT

INTRODUCTION: Intestinal parasitoses are very common infections in tropical areas. By contrast, they are rarely diagnosed in developed countries, and are mostly seen in specific populations. PATIENTS AND METHODS: This analytical observational study was longitudinally performed in a French university hospital (2007-2011). It dealt with the study of gastrointestinal carriage of parasites in internationally adopted children. A standard stool examination was therefore systematically undertaken for every new immigrant. Association with risk factors was made by uni- and multivariate analysis. RESULTS: Overall, 69 stool samples were analyzed. The proportion of positive samples was 78 %. Protozoans, mainly Giardia duodenalis, were more prevalent than helminths. In univariate analysis, a subject's low weight and height were significantly associated with intestinal parasite carriage. Amoebae were more frequent in older children and in children from Haiti, as confirmed by the trend observed in the multivariate analysis. Flagellates were seen more often in African children. Infections with multiple parasite species were observed in half of the study population, and were inversely correlated to increasing age. DISCUSSION: According to the results of this study, gastrointestinal parasites are still very frequent in stool samples from immigrant children. Since they are easy to transmit, the majority of infections were protozoan. The best antiparasitic strategy lies in: (a) the routine screening of stool from any immigrant child coming from endemic areas and (b) the use of antiparasitic treatment.


Subject(s)
Adoption , Emigrants and Immigrants , Feces/parasitology , Intestinal Diseases, Parasitic/epidemiology , Child , Child, Preschool , Female , France/epidemiology , Humans , Infant , Male , Prevalence
8.
Am J Transplant ; 16(9): 2670-5, 2016 09.
Article in English | MEDLINE | ID: mdl-26990694

ABSTRACT

Pretransplantation adaptation of the daily dose of tacrolimus to CYP3A5 genotype is associated with improved achievement of target trough concentration (C0 ), but whether this improvement affects clinical outcomes is unknown. In the present study, we have evaluated the long-term clinical impact of the adaptation of initial tacrolimus dosing according to CYP3A5 genotype: The transplantation outcomes of the 236 kidney transplant recipients included in the Tactique study were retrospectively investigated over a period of more than 5 years. In the Tactique study, patients were randomly assigned to receive tacrolimus at either a fixed dosage or a dosage determined by their genotype, and the primary efficacy end point was the proportion of patients for whom tacrolimus C0 was within target range (10-15 ng/mL) at day 10. Our results indicate that the incidence of biopsy-proven acute rejection and graft survival were similar between the control and the adapted tacrolimus dose groups, as well as between the patients who achieve the tacrolimus C0 target ranges earlier. Patients' death, cancer, cardiovascular events, and infections were also similar, and renal function did not change. We conclude that optimization of initial tacrolimus dose using pharmacogenetic testing does not improve clinical outcomes.


Subject(s)
Cytochrome P-450 CYP3A/genetics , Graft Rejection/drug therapy , Kidney Failure, Chronic/genetics , Kidney Transplantation/adverse effects , Pharmacogenetics , Tacrolimus/administration & dosage , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Genotype , Glomerular Filtration Rate , Graft Rejection/etiology , Graft Survival , Humans , Immunosuppressive Agents/pharmacokinetics , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/surgery , Kidney Function Tests , Male , Middle Aged , Prognosis , Prospective Studies , Risk Factors , Tacrolimus/pharmacokinetics , Tissue Distribution
10.
Ann Dermatol Venereol ; 141(3): 201-5, 2014 Mar.
Article in French | MEDLINE | ID: mdl-24635954

ABSTRACT

BACKGROUND: Mucormycosis are rare fungal infections occurring chiefly in the lung or the rhinocerebral compartment, particularly in patients with immunodeficiency or mellitus diabetes. We report the case of an elderly patient with cutaneous mucormycosis caused by Rhizopus microsporus. PATIENTS AND METHODS: An 89-year-old man presented a skin lesion of the forearm rapidly becoming inflammatory and necrotic. The patient had been treated for 2months with oral corticosteroids for idiopathic thrombocytopenia. Histological and mycological examination of the skin biopsy revealed the presence of a filamentous fungus, R. microsporus. The outcome was unfavorable, despite prescription of high-dose liposomal amphotericin B. DISCUSSION: Mucormycosis are infrequent opportunistic infections caused by angio-invasive fungi belonging to the Mucorales order. Cutaneous presentations are rare, and in rare cases the species R. microsporus is isolated in clinical samples. Diagnosis is based on histological examination highlighting the characteristic mycelium within infected tissue, together with ex vivo mycological identification using morphological and molecular methods. Treatment consists of liposomal amphotericin B combined with debridement surgery. CONCLUSION: R. microsporus is a marginal fungal species rarely isolated in clinical practice, and even less in dermatology departments. This clinical case report highlights the severity of infection with this fungus, particularly in the absence of early surgery.


Subject(s)
Dermatomycoses/diagnosis , Dermatomycoses/microbiology , Mucormycosis/diagnosis , Mucormycosis/microbiology , Opportunistic Infections/diagnosis , Opportunistic Infections/microbiology , Rhizopus , Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Aged, 80 and over , Amphotericin B/administration & dosage , Biopsy , Dermatomycoses/drug therapy , Dermatomycoses/pathology , Dose-Response Relationship, Drug , Humans , Male , Mucormycosis/drug therapy , Mucormycosis/pathology , Necrosis , Opportunistic Infections/drug therapy , Opportunistic Infections/pathology , Palliative Care , Rhizopus/ultrastructure , Skin/pathology , Thrombocytopenia/drug therapy
11.
Med Mal Infect ; 44(3): 89-101, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24548415

ABSTRACT

Invasive pulmonary aspergillosis is an opportunistic mycosis, difficult to diagnose, due to the environmental fungi of the genus Aspergillus. The diagnostic tools, even if more are available, are still limited in number and effectiveness. The current recommendations issued by the EORTC/MSG (European Organization of Research and Treatment of Cancer/Mycoses Study Group) and the ECIL (European Conference for Infection in Leukemia) suggest collecting epidemiological, radio-clinical, and biological data to support the diagnosis of aspergillosis with a strong presumption. Thus, medical imaging and serum galactomannan antigen currently constitute the basis of the screening approach, although they both have some limitations in specificity. (1→3)-ß-D-glucans are pan-fungal serum markers with a very good negative predictive value. Real-time PCR lacks standardization, and fungal culture from respiratory specimens is sometimes not sensitive enough. Histology allows proving the diagnosis of aspergillosis, but biopsy is not always possible in immunodepressed patients. We present the various arguments for the diagnosis of invasive aspergillosis, with a particular emphasis on recent exploration techniques.


Subject(s)
Invasive Pulmonary Aspergillosis/diagnosis , Antibodies, Fungal/blood , Antigens, Fungal/blood , Aspergillus/growth & development , Aspergillus/immunology , Aspergillus/isolation & purification , Biomarkers , Biopsy , DNA, Fungal/analysis , Diagnostic Imaging , Early Diagnosis , Europe , Galactose/analogs & derivatives , Humans , Immunocompromised Host , Invasive Pulmonary Aspergillosis/blood , Invasive Pulmonary Aspergillosis/epidemiology , Invasive Pulmonary Aspergillosis/pathology , Mannans/blood , Practice Guidelines as Topic , Predictive Value of Tests , Real-Time Polymerase Chain Reaction , Sensitivity and Specificity , Tomography, X-Ray Computed , beta-Glucans/blood
12.
Clin Microbiol Infect ; 20(8): 784-90, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24355037

ABSTRACT

Trichosporon spp. have recently emerged as significant human pathogens. Identification of these species is important, both for epidemiological purposes and for therapeutic management, but conventional identification based on biochemical traits is hindered by the lack of updates to the species databases provided by the different commercial systems. In this study, 93 strains, or isolates, belonging to 16 Trichosporon species were subjected to both molecular identification using IGS1 gene sequencing and matrix-assisted laser desorption ionisation-time-of-flight (MALDI-TOF) analysis. Our results confirmed the limits of biochemical systems for identifying Trichosporon species, because only 27 (36%) of the isolates were correctly identified using them. Different protein extraction procedures were evaluated, revealing that incubation for 30 min with 70% formic acid yields the spectra with the highest scores. Among the six different reference spectra databases that were tested, a specific one composed of 18 reference strains plus seven clinical isolates allowed the correct identification of 67 of the 68 clinical isolates (98.5%). Although until recently it has been less widely applied to the basidiomycetous fungi, MALDI-TOF appears to be a valuable tool for identifying clinical Trichosporon isolates at the species level.


Subject(s)
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Trichosporon/chemistry , Trichosporon/classification , Trichosporonosis/diagnosis , Trichosporonosis/microbiology , Fungal Proteins/chemistry , Fungal Proteins/isolation & purification , Humans , Sensitivity and Specificity , Specimen Handling/methods , Trichosporon/isolation & purification
13.
Transpl Infect Dis ; 15(6): E250-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24298986

ABSTRACT

We report the first successful use, to our knowledge, of fumagillin alone in a pediatric patient to cure intestinal microsporidiosis in a liver-kidney transplanted child. Detection of Enterocytozoon bieneusi in stool became negative from the first post-therapeutic control, while digestive symptoms disappeared in 4 days. During a 9-month follow-up, polymerase chain reaction and direct examinations remained negative for microsporidia in her feces. No major undesirable effects were noted during the anti-microsporidial therapy.


Subject(s)
Antifungal Agents/therapeutic use , Cyclohexanes/therapeutic use , Enterocytozoon/isolation & purification , Fatty Acids, Unsaturated/therapeutic use , Kidney Transplantation/adverse effects , Liver Transplantation/adverse effects , Microsporidiosis/drug therapy , Child , Child, Preschool , Diarrhea/microbiology , Enterocytozoon/genetics , Feces/microbiology , Female , Humans , Microsporidiosis/microbiology , Sesquiterpenes/therapeutic use
14.
Gynecol Obstet Fertil ; 41(11): 627-34, 2013 Nov.
Article in French | MEDLINE | ID: mdl-24183578

ABSTRACT

OBJECTIVES: Prospective evaluation of symptoms and quality of life before and after surgical treatment of endometriosis with bowel involvement. PATIENTS AND METHODS: Changes in symptoms, sexuality and quality of life before and after surgery of 41 patients operated for bowel endometriosis at the centre hospitalier de Versailles (CHV) were assessed with a self-assessment questionnaire. Pains were assessed using five visual analog scales, symptoms using 26 questions with a four-level Likert item, sexuality using the SEXACQ, and quality of life using the EHP-5 and the EQ-5D VAS. RESULTS: Surgical treatment improves pain: VAS scores for main pain (P<0.0001), dysmenorrhea (P=0.0039), defecation pain (P=0.0312), non-cyclic pelvic pain (P=0.0002), and dyspareunia (P=0.0084). Twelve intestinal symptoms are improved, including three significantly. It also improves SEXACQ score (P=0.0068) and quality of life scores EHP-5 and EQ-5D VAS (P=0.0001 and P=0.0003 respectively). No difference was found between disk resection and segmental resection in terms of symptoms, sexuality and quality of life. Histological analysis suggests that when a segmental resection is done, the stage of the endometriosis bowel involvement is more advanced. DISCUSSION AND CONCLUSION: Surgery of bowel endometriosis improves symptoms and quality of life. When the stage of the bowel endometriosis is advanced, a segmental resection should be done. Moreover, self-assessment questionnaire used at the CHV seems an appropriate tool to evaluate functional outcome.


Subject(s)
Endometriosis/surgery , Intestinal Diseases/surgery , Quality of Life , Adult , Female , Humans , Prospective Studies , Sexuality , Surveys and Questionnaires , Visual Analog Scale , Young Adult
15.
J Mycol Med ; 23(3): 168-75, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23871385

ABSTRACT

Eumycetomas are chronic infectious entities characterized by presence of mycotic grains in (sub-)cutaneous tissues, after accidental inoculation of an exogenous filamentous fungus in the skin. The lesions evolve towards painless pseudotumor of the soft parts. We report the original case of a Guinean woman exhibiting eumycetoma of the right foot. Both laboratory tests identified a dematiaceous fungus, Exophiala jeanselmei, as the responsible infectious agent. A medical treatment with voriconazole alone was sufficient to notice a substantial clinical improvement. This finding is unusual as E. jeanselmei is uncommon in Guinea-Conakry, and as optimal treatment rather associate antifungal azoles and surgical excision.


Subject(s)
Exophiala/physiology , Foot Diseases/microbiology , Mycetoma/microbiology , Adult , Exophiala/isolation & purification , Female , Foot Diseases/diagnostic imaging , Guinea , Humans , Mycetoma/diagnostic imaging , Ultrasonography
16.
J Antimicrob Chemother ; 67(6): 1493-5, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22374323

ABSTRACT

OBJECTIVES: Chronic disseminated candidiasis (CDC) is a disseminated fungal infection that is frequently seen in patients undergoing intensive treatment of haematological malignancies. The first signs of CDC appear during neutrophil recovery. Clinical and physiopathological characteristics of CDC suggest it belongs to the spectrum of fungus-related immune reconstitution inflammatory syndrome (IRIS). We report five cases of CDC treated with antifungal therapy and adjuvant corticosteroids to decrease the exacerbated inflammatory response. METHODS: We conducted a retrospective study in the Haematology Department of the University Hospital of Tours, France. The five reported cases were treated for CDC with antifungal therapy and adjuvant corticosteroids. RESULTS: Of the five cases of CDC, one was proven and four were possible, according to the 2008 European Organization for Research and Treatment of Cancer (EORTC) classification. All patients were being treated for acute leukaemia. In all cases, symptoms disappeared 2.8 days (range, 1-7) after the beginning of adjunctive corticosteroid therapy. Corticosteroids were administered on average for 146 days (range, 4 weeks-1 year) and antifungal therapy was administered for the duration of chemotherapy consolidation. There was no exacerbation of CDC symptoms during the next round of chemotherapy or bone marrow transplantation. One patient died from relapse of leukaemia. CONCLUSIONS: Within the framework of IRIS, adjuvant corticosteroid therapy could rapidly improve CDC symptoms and allow continued chemotherapy without delay and without compromising the haematological prognosis.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Candidiasis/drug therapy , Antifungal Agents/administration & dosage , Candidiasis/pathology , Chronic Disease , Drug Therapy, Combination/methods , France , Hematologic Neoplasms/complications , Humans , Immune Reconstitution Inflammatory Syndrome/drug therapy , Immune Reconstitution Inflammatory Syndrome/pathology , Retrospective Studies , Treatment Outcome
17.
Mycoses ; 52(3): 239-45, 2009 May.
Article in English | MEDLINE | ID: mdl-19383006

ABSTRACT

Invasive pulmonary aspergillosis (IPA) is of particular concern to immunodeficient patients, whose mortality rates may exceed 80%. The development of an animal model that faithfully reproduces the pathophysiology of IPA would improve the studies on diagnostic and therapeutic modes, and the use of rats as a possible model for IPA seems to have been largely overlooked. Such a model could be established with the MicroSprayer IA-1B. Male Sprague-Dawley rats (6-8 weeks old) were rendered immunodeficient by cyclophosphamide injections and a protein-deficient diet. On day D0, they were anaesthetised by inhalation of 5% isoflurane and infected by the intra-tracheal aerosolization of 100 microl of an Aspergillus fumigatus spore suspension through a MicroSprayer IA-1B. This inoculation process was simple and rapid, with no deaths observed during or immediately after the procedure. The rats regained consciousness within 1 min. Follow-up data including those for clinical factors (weight changes, mortality rate), biological factors (Aspergillus antigens) and histological factors were consistent with previous studies. The advantages of this model include the ease of animal manipulation, the reproducibility of infection and the potential for repeated blood sampling.


Subject(s)
Aspergillus fumigatus/physiology , Disease Models, Animal , Invasive Pulmonary Aspergillosis/microbiology , Animals , Humans , Invasive Pulmonary Aspergillosis/mortality , Male , Nebulizers and Vaporizers , Rats , Rats, Sprague-Dawley , Spores, Fungal/physiology , Trachea/microbiology
18.
Mol Cell Biol ; 19(10): 6872-90, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10490625

ABSTRACT

By selectively eliminating ubiquitin-conjugated proteins, the 26S proteasome plays a pivotal role in a large variety of cellular regulatory processes, particularly in the control of cell cycle transitions. Access of ubiquitinated substrates to the inner catalytic chamber within the 20S core particle is mediated by the 19S regulatory particle (RP), whose subunit composition in budding yeast has been recently elucidated. In this study, we have investigated the cell cycle defects resulting from conditional inactivation of one of these RP components, the essential non-ATPase Rpn3/Sun2 subunit. Using temperature-sensitive mutant alleles, we show that rpn3 mutations do not prevent the G(1)/S transition but cause a metaphase arrest, indicating that the essential Rpn3 function is limiting for mitosis. rpn3 mutants appear severely compromised in the ubiquitin-dependent proteolysis of several physiologically important proteasome substrates. Thus, RPN3 function is required for the degradation of the G(1)-phase cyclin Cln2 targeted by SCF; the S-phase cyclin Clb5, whose ubiquitination is likely to involve a combination of E3 (ubiquitin protein ligase) enzymes; and anaphase-promoting complex targets, such as the B-type cyclin Clb2 and the anaphase inhibitor Pds1. Our results indicate that the Pds1 degradation defect of the rpn3 mutants most likely accounts for the metaphase arrest phenotype observed. Surprisingly, but consistent with the lack of a G(1) arrest phenotype in thermosensitive rpn3 strains, the Cdk inhibitor Sic1 exhibits a short half-life regardless of the RPN3 genotype. In striking contrast, Sic1 turnover is severely impaired by a temperature-sensitive mutation in RPN12/NIN1, encoding another essential RP subunit. While other interpretations are possible, these data strongly argue for the requirement of distinct RP subunits for efficient proteolysis of specific cell cycle regulators. The potential implications of these data are discussed in the context of possible Rpn3 function in multiubiquitin-protein conjugate recognition by the 19S proteasomal regulatory particle.


Subject(s)
Cell Cycle Proteins/metabolism , Cysteine Endopeptidases/metabolism , Multienzyme Complexes/metabolism , Repressor Proteins , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/cytology , Ubiquitins/metabolism , Amino Acid Sequence , Cyclin B/metabolism , Cyclin-Dependent Kinase Inhibitor Proteins , Cyclins/metabolism , Fungal Proteins/metabolism , G1 Phase , Mitosis , Molecular Sequence Data , Nuclear Proteins/metabolism , Peptide Synthases/metabolism , Proteasome Endopeptidase Complex , S Phase , SKP Cullin F-Box Protein Ligases , Saccharomyces cerevisiae/enzymology , Securin , Sequence Homology, Amino Acid
19.
Genes Dev ; 13(9): 1190-202, 1999 May 01.
Article in English | MEDLINE | ID: mdl-10323869

ABSTRACT

Cell cycle-specific proteolysis is critical for proper execution of mitosis in all eukaryotes. Ubiquitination and subsequent proteolysis of the mitotic regulators Clb2 and Pds1 depend on the cyclosome/APC and the 26S proteasome. We report here that components of the cell cycle machinery in yeast, specifically the cell cycle regulatory cyclin-dependent kinase Cdc28 and a conserved associated protein Cks1/Suc1, interact genetically, physically, and functionally with components of the 26S proteasome. A mutation in Cdc28 (cdc28-1N) that interferes with Cks1 binding, or inactivation of Cks1 itself, confers stabilization of Clb2, the principal mitotic B-type cyclin in budding yeast. Surprisingly, Clb2-ubiquitination in vivo and in vitro is not affected by mutations in cks1, indicating that Cks1 is not essential for cyclosome/APC activity. However, mutant Cks1 proteins no longer physically interact with the proteasome, suggesting that Cks1 is required for some aspect of proteasome function during M-phase-specific proteolysis. We further provide evidence that Cks1 function is required for degradation of the anaphase inhibitor Pds1. Stabilization of Pds1 is partially responsible for the metaphase arrest phenotype of cks1 mutants because deletion of PDS1 partially relieves the metaphase block in these mutants.


Subject(s)
Cell Cycle Proteins , Cyclin B , Cyclin-Dependent Kinases/metabolism , Cysteine Endopeptidases/metabolism , Fungal Proteins/metabolism , Multienzyme Complexes/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Schizosaccharomyces pombe Proteins , Ubiquitin-Protein Ligase Complexes , Adaptor Proteins, Signal Transducing , Anaphase-Promoting Complex-Cyclosome , Base Sequence , CDC28 Protein Kinase, S cerevisiae/genetics , CDC28 Protein Kinase, S cerevisiae/metabolism , Cyclin-Dependent Kinases/genetics , Cyclins/genetics , Cyclins/metabolism , Cysteine Endopeptidases/genetics , DNA Primers/genetics , Endopeptidases/metabolism , Enhancer Elements, Genetic , Fungal Proteins/genetics , Genes, Fungal , Ligases/genetics , Ligases/metabolism , Metaphase , Mitosis , Multienzyme Complexes/genetics , Mutation , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phenotype , Proteasome Endopeptidase Complex , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/genetics , Securin , Temperature , Ubiquitin-Protein Ligases , Ubiquitins/metabolism
20.
Mycoses ; 41(3-4): 113-6, 1998.
Article in English | MEDLINE | ID: mdl-9670762

ABSTRACT

We report a case of systemic infection with Geotrichum capitatum in a patient with acute myeloid leukaemia. Three days before death, the patient developed acute renal failure, probably caused by occlusion of glomerula with hyphae of G. capitatum. Up until now, prophylaxis and treatment of infections caused by Geotrichum capitatum have not been established. However, the prophylactic administration of high-dose itraconazole and the therapeutic use of liposomal amphotericin B are subjects of discussion.


Subject(s)
Fungemia/complications , Geotrichosis/complications , Leukemia, Myeloid/complications , Neutropenia/complications , Acute Disease , Acute Kidney Injury , Blood/microbiology , Fungemia/drug therapy , Geotrichosis/drug therapy , Humans , Kidney Glomerulus/pathology , Libya/ethnology , Lung/diagnostic imaging , Lung/pathology , Male , Middle Aged , Radiography , Tomography
SELECTION OF CITATIONS
SEARCH DETAIL
...